てだこ整形外科
Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.
The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →
Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive
02G2512002 +3Location
- Prefecture
- Okinawa
- Address
- 浦添市前田3丁目13番28号 メディカルスクエアてだこ浦西 3F
Plan classification
- Class INot registered
- Class IIThe medium-risk category under the law.
- Class IIIThe low-risk category under the law.
Certified committee for regenerative medicine
- ICVS特定認定再生医療等委員会
- 日本薬事法務学会再生医療等委員会
Public score
58.8/ 100
- A · Review level
- 25.0 / 30
- B · Technologies
- 18.5 / 35
- C · Coverage
- 10.7 / 25
- D · Class I / II technologies
- 4.6 / 10
The public score is calculated from public registration information and does not reflect quality of care. Scoring method →
Registered technologies (4)
Stem cells (all sources) 2
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自家脂肪組織由来幹細胞を用いた変形性関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
| 自家脂肪組織由来幹細胞を用いた慢性疼痛の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
Adipose-derived stem cells 2
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自家脂肪組織由来幹細胞を用いた変形性関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
| 自家脂肪組織由来幹細胞を用いた慢性疼痛の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
NK and immune cells 2
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 成分採血での悪性腫瘍の抑制及び治療のためのGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®) | NK and immune cells | Class III |
| 全血採血での悪性腫瘍の抑制及び治療のためのGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®Ⅱ) | NK and immune cells | Class III |
Joints and musculoskeletal 1
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自家脂肪組織由来幹細胞を用いた変形性関節症の治療 | Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletal | Class II |
Certified committee for regenerative medicine
- ICVS特定認定再生医療等委員会
- 日本薬事法務学会再生医療等委員会
Public document number
02G251200201G251200501G250900501G2509006
Plan classification · Certified committee for regenerative medicine · Public document number
| Registered technologies | Plan classification | Certified committee for regenerative medicine | Public document number |
|---|---|---|---|
| 自家脂肪組織由来幹細胞を用いた変形性関節症の治療 | Class II | ICVS特定認定再生医療等委員会 | 02G2512002 |
| 自家脂肪組織由来幹細胞を用いた慢性疼痛の治療 | Class II | ICVS特定認定再生医療等委員会 | 01G2512005 |
| 成分採血での悪性腫瘍の抑制及び治療のためのGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®) | Class III | 日本薬事法務学会再生医療等委員会 | 01G2509005 |
| 全血採血での悪性腫瘍の抑制及び治療のためのGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®Ⅱ) | Class III | 日本薬事法務学会再生医療等委員会 | 01G2509006 |
Other institutions in the same prefecture
- 医療法人形成会 当山美容形成外科Public score 59.8
- 当山美容形成外科Public score 52.9
- 一般社団法人国際和合医療学会 高輪アイランドクリニックPublic score 51.2
- ロクト整形AzPublic score 47.7
- 医療法人八重瀬会 同仁病院Public score 47.7
- はねじ歯科クリニックPublic score 43.0
- 医療法人徳洲会 南部徳洲会病院Public score 43.0
- 社会医療法人友愛会友愛医療センターPublic score 43.0